In diabetes, chronic hyperglycemia leads to oxidative modification and non-enzymatic glycation of HDL-associated proteins, including apolipoprotein A-I and paraoxonase-1, resulting in impaired cholesterol efflux capacity, reduced antioxidative activity, and a shift toward a pro-inflammatory HDL phenotype. This evidence concerns the gene APOA1 and diabetes mellitus.